Comparison and analysis between CLL-hBMSC and N-hBMSC.
10.7534/j.issn.1009-2137.2014.04.007
- Author:
Huan WANG
1
;
Jun ZHOU
1
;
Jing-Jing XU
1
;
Feng GUO
2
Author Information
1. Central Laboratory, The First Affiliated Hospital of Soochow University, Suzhou 215006, Jiangsu Province,China.
2. Central Laboratory, The First Affiliated Hospital of Soochow University, Suzhou 215006, Jiangsu Province,China. E-mail: guofeng27@suda.edu.
- Publication Type:Journal Article
- MeSH:
Humans;
Intercellular Adhesion Molecule-1;
metabolism;
Leukemia, Lymphocytic, Chronic, B-Cell;
genetics;
metabolism;
pathology;
Lymphotoxin beta Receptor;
metabolism;
Mesenchymal Stromal Cells;
cytology;
metabolism;
Signal Transduction;
Transcription Factor RelA;
metabolism;
Transcription Factor RelB;
metabolism;
Vascular Cell Adhesion Molecule-1;
metabolism
- From:
Journal of Experimental Hematology
2014;22(4):914-919
- CountryChina
- Language:Chinese
-
Abstract:
This study was purpose to compare and analyze the chronic lymphocytic leukemia human bone marrow stromal cells (CLL-hBMSC) and normal hBMSC (N-hBMSC) so as to provide theoretical evidence for establishment of CLL-hBMSC interaction model to imitate CLL microenvironment. Mononuclear cells (MNC) were isolated from bone marrow of CLL patients and healthy donors and then were cultured, hBMSC were established by expanding for at least five passages. The mRNA expression of adhesion molecules, such as vascular cell adhesion molecule 1 (VCAM-1) and intercellular adhesion molecule 1 (ICAM-1), was analyzed by real-time PCR. The mRNA and protein expression of lymphotoxin beta receptor (LTβR) were determined by real-time PCR and Western blot, respectively. The individual NF-κB members at protein level of CLL-hBMSC and N-hBMSC were examined by Western blot. The effect of LTα1β2 on individual NF-κB family members at protein level in CLL-hBMSC and N-hBMSC was also examined by Western blot. The death of CLL cells was determined by flow cytometry with PI staining when cultured with or without CLL-hBMSC and N-hBMSC at different time points. The results showed that the hBMSC could be established successfully from bone marrow of CLL patients, which were similar to N-hBMSC. Adhesion molecules, such as VCAM-1 and ICAM-1, were found to be expressed at similar mRNA levels in CLL-hBMSC and N-hBMSC. LTβR expressions at mRNA and protein levels were comparable between CLL-hBMSC and N-hBMSC. The protein expression of the individual NF-κB family members could be detected in CLL-hBMSC and N-hBMSC with similar expression levels. LTα1β2 stimulation activated both the classical ( RelA/p50 ) and alternative ( RelB/p52 ) NF-κB complexes in CLL-hBMSC and N-hBMSC. The capacities of CLL-hBMSC and N-hBMSC to protect CLL cell survival were similar. It is concluded that there is no statistical difference between bone marrow from healthy donors and CLL patients in the efficiency of generating of hBMSC. LTβR-NF-κB signaling molecules are expressed and activated on hBMSC with a similar pattern.
